OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Activation of ACLY by SEC63 deploys metabolic reprogramming to facilitate hepatocellular carcinoma metastasis upon endoplasmic reticulum stress
Chen-Yu Hu, Zechang Xin, Xiaoyan Sun, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 24

Showing 24 citing articles:

LncRNA-HMG incites colorectal cancer cells to chemoresistance via repressing p53-mediated ferroptosis
Zechang Xin, Chen-Yu Hu, Chunfeng Zhang, et al.
Redox Biology (2024) Vol. 77, pp. 103362-103362
Open Access | Times Cited: 5

Targeting lipid metabolism in cancer metastasis
Gloria Pascual, Blanca Majem, Salvador Aznar Benitah
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189051-189051
Closed Access | Times Cited: 10

Targeting Lipid Metabolism in Cancer Stem Cells for Anticancer Treatment
Manish Kumar Singh, Sunhee Han, Sung Soo Kim, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11185-11185
Open Access | Times Cited: 3

The switch triggering the invasion process: Lipid metabolism in the metastasis of hepatocellular carcinoma
Jiaqian Zhang, Zhicheng Zhang, Zhangfan Wu, et al.
Chinese Medical Journal (2024) Vol. 137, Iss. 11, pp. 1271-1284
Open Access | Times Cited: 2

Regulation mechanism of endoplasmic reticulum stress on metabolic enzymes in liver diseases
Shaojun Zhou, Kaiwen Cheng, Yi‐Jen Peng, et al.
Pharmacological Research (2024) Vol. 207, pp. 107332-107332
Open Access | Times Cited: 2

ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma
Weichen Wang, Dongquan Liu, Jiaming Yao, et al.
Medical Science Monitor (2024) Vol. 30
Open Access | Times Cited: 1

BMI1 overexpression is correlated with a poor prognosis and immune infiltration in hepatocellular carcinoma
Mincong Wang, Pengtao Yang, Yang Zhang, et al.
Oncology and Translational Medicine (2024) Vol. 10, Iss. 2, pp. 60-65
Open Access | Times Cited: 1

FOXM1 Upregulates O-GlcNAcylation Level Via The Hexosamine Biosynthesis Pathway to Promote Angiogenesis in Hepatocellular Carcinoma
Xiaorong Zhang, Yifan Zhong, Qing Yang
Cell Biochemistry and Biophysics (2024) Vol. 82, Iss. 3, pp. 2767-2785
Closed Access | Times Cited: 1

Precise targeting of lipid metabolism in the era of immuno-oncology and the latest advances in nano-based drug delivery systems for cancer therapy
Hongyan Zhang, Yujie Li, Jingyi Huang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 11, pp. 4717-4737
Open Access | Times Cited: 1

The crosstalk between cellular survival pressures and N6-methyladenosine modification in hepatocellular carcinoma
Chu‐Li Fu, Zhengwei Zhao, Qiangnu Zhang
Hepatobiliary & pancreatic diseases international (2024)
Closed Access | Times Cited: 1

An Analysis Regarding the Association Between the Nuclear Pore Complex (NPC) and Hepatocellular Carcinoma (HCC)
Pan Huang, Yi-dou Hu, Yuan-jie Liu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 959-978
Open Access | Times Cited: 4

TRIM55 Promotes Proliferation of Hepatocellular Carcinoma Through Stabilizing TRIP6 to Activate Wnt/β-Catenin Signaling
Xun Lu, Yue Yuan, Ning Cai, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1281-1293
Open Access | Times Cited: 2

CircFSCN1 induces tumor progression and triggers epithelial–mesenchymal transition in bladder cancer through augmentation of MDM2-mediated p53 silencing
Wen Deng, Ru Chen, Situ Xiong, et al.
Cellular Signalling (2023) Vol. 114, pp. 110982-110982
Closed Access | Times Cited: 2

RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer
Jin-shu Pang, Xiu-Mei Bai, Weijun Wan, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 285-304
Open Access

MTFR2 accelerates hepatocellular carcinoma mediated by metabolic reprogramming via the Akt signaling pathway
Zhongming Bao, Ming Yang, Yunhu Guo, et al.
Cellular Signalling (2024) Vol. 123, pp. 111366-111366
Closed Access

FXR, MRP-1 and SLC7A5: New Targets for the Treatment of Hepatocellular Carcinoma
Xiyue Zhang, Ming Luo, Qin Shu, et al.
Technology in Cancer Research & Treatment (2024) Vol. 23
Open Access

The Q for immune evasion in HCC: ER stress in myeloid cells
Charlotte Rennert, Maike Hofmann
Gut (2024), pp. gutjnl-333249
Open Access

The pathological significance and potential mechanism of ACLY in cholangiocarcinoma
Xiaoyan Sun, Xiaofang Zhao, Senyan Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

ARL8B promotes hepatocellular carcinoma progression and inhibits antitumor activity of lenvatinib via MAPK/ERK signaling by interacting with RAB2A
Momo Cao, Yiming Li, Xiang Ding, et al.
Cellular Signalling (2024) Vol. 124, pp. 111470-111470
Closed Access

The N‐terminal domain of gasdermin D induces liver fibrosis by reprogrammed lipid metabolism
Xue Wang, Chunyou Ning, Xingyi Cheng, et al.
Animal Models and Experimental Medicine (2024)
Open Access

Downregulated Acetyl-CoA Acyltransferase 2 Promoted the Progression of Hepatocellular Carcinoma and Participated in the Formation of Immunosuppressive Microenvironment
Dehai Wu, Guanqun Liao, Yuanfei Yao, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1327-1339
Open Access | Times Cited: 1

Page 1

Scroll to top